Ang-1 promotes tumorigenesis and mediates the anti-cancer effects of Artesunate on Choroidal melanoma via the regulation of Akt/mTOR signaling pathway

[Display omitted] The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts in...

Full description

Saved in:
Bibliographic Details
Published inCytokine (Philadelphia, Pa.) Vol. 184; p. 156771
Main Authors Yao, Ningning, Ma, Qingyue, Yi, Wendan, Liu, Yichong, Zhang, Qian, Gao, Xiaodi, Zhao, Xintong, Wang, Haowen, Lei, Ke, Sui, Aihua, Luo, Wenjuan
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [Display omitted] The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells’ proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART.
AbstractList The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells' proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART.The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells' proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART.
The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells' proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART.
[Display omitted] The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells’ proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART.
ArticleNumber 156771
Author Wang, Haowen
Lei, Ke
Yao, Ningning
Gao, Xiaodi
Sui, Aihua
Luo, Wenjuan
Yi, Wendan
Liu, Yichong
Zhao, Xintong
Zhang, Qian
Ma, Qingyue
Author_xml – sequence: 1
  givenname: Ningning
  surname: Yao
  fullname: Yao, Ningning
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 2
  givenname: Qingyue
  surname: Ma
  fullname: Ma, Qingyue
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 3
  givenname: Wendan
  surname: Yi
  fullname: Yi, Wendan
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 4
  givenname: Yichong
  surname: Liu
  fullname: Liu, Yichong
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 5
  givenname: Qian
  surname: Zhang
  fullname: Zhang, Qian
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 6
  givenname: Xiaodi
  surname: Gao
  fullname: Gao, Xiaodi
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 7
  givenname: Xintong
  surname: Zhao
  fullname: Zhao, Xintong
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 8
  givenname: Haowen
  surname: Wang
  fullname: Wang, Haowen
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 9
  givenname: Ke
  surname: Lei
  fullname: Lei, Ke
  organization: Tumor Immunology and Cytotherapy of Medical Research Center and Key Laboratory of Pancreatic Disease Clinical Research (Shandong Province), The Affiliated Hospital of Qingdao University, Qingdao 266000, China
– sequence: 10
  givenname: Aihua
  surname: Sui
  fullname: Sui, Aihua
  organization: Center Laboratory, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
– sequence: 11
  givenname: Wenjuan
  surname: Luo
  fullname: Luo, Wenjuan
  email: luowenjuan@qdu.edu.cn
  organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39340959$$D View this record in MEDLINE/PubMed
BookMark eNp9kctuGyEYRlGVqkncvkAXFctuxoFhLkHqxrLSJFKkSJW7Rgz8jHFnwAUmkV-kzxvGTjZdZMXtHATfd4nOnHeA0FdKlpTQ5mq3VIfklyUpqyWtm7alH9AFJbwpCCnZ2TyvWFE1TXOOLmPcEUI4a9tP6JxxVhFe8wv0b-X6guJ98KNPEHGaRh9sDw6ijVg6jUfQVh6PtpA3ki2UdAoCBmNApYi9wauQgcllDHuH11sfvNVyyO4gnR8lfrLy6Afop0Emm6lZ-5Ouxs3jLxxt7-RgXY_3Mm2f5eEz-mjkEOHL67hAv3_ebNZ3xcPj7f169VAoVjep0IwbTqq6rDiRTNPGcOioqY0GySjTHWm5ulZ5YWrSmfx7poGVvIO6NFx2bIG-n-7NAfydICYx2qhgyM8GP0XBaM6TljVpM_rtFZ26nInYBzvKcBBvWWbg-gSo4GMMYISy6fjXFKQdBCVirk3sxFybmGsTp9qyWv6nvt3-rvTjJEEO6MlCEFFZyNVoG3IxQnv7nv4C8GOz0Q
CitedBy_id crossref_primary_10_3389_fphar_2024_1483049
Cites_doi 10.1016/S0002-9440(10)63998-3
10.3892/ijo.2021.5190
10.1016/j.preteyeres.2018.03.004
10.1080/21655979.2020.1834727
10.1016/j.gene.2020.145134
10.3390/ijms20051164
10.18632/oncotarget.6981
10.3390/molecules22081272
10.1016/j.ophtha.2016.01.023
10.1002/ijc.33381
10.1016/j.preteyeres.2019.100800
10.1093/cid/ciz206
10.1054/bjoc.2000.1437
10.3390/cancers13225730
10.1139/bcb-2021-0275
10.1007/s00706-021-02759-x
10.1038/s41401-020-0395-5
10.1111/jcmm.14717
10.3389/fonc.2021.714646
10.1016/j.leukres.2017.05.007
10.1046/j.1469-7580.2002.00061.x
10.2174/1568009618666180425142653
10.2147/OPTH.S89591
10.1155/2021/9911537
10.1172/JCI4891
10.1016/S0002-9440(10)63413-X
10.1006/excr.2002.5597
10.1007/s12185-010-0697-3
10.1038/s41419-023-05712-4
10.1016/S0002-9440(10)62565-5
10.1016/j.yexmp.2019.01.006
10.1186/s12943-019-1030-2
10.1038/s41598-017-00079-x
10.1080/21655979.2022.2042141
10.3748/wjg.14.1575
10.3390/ijms21249651
10.1016/j.semcancer.2019.07.009
10.1002/jcb.27889
10.1007/978-94-007-6627-3_46
10.1016/j.neo.2017.02.002
10.1016/j.cell.2010.06.011
ContentType Journal Article
Copyright 2024 Elsevier Ltd
Copyright © 2024 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2024 Elsevier Ltd
– notice: Copyright © 2024 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.cyto.2024.156771
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1096-0023
ExternalDocumentID 39340959
10_1016_j_cyto_2024_156771
S1043466624002758
Genre Journal Article
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29F
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AAAJQ
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABUDA
ABXDB
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFJKZ
AFKWA
AFTJW
AFXIZ
AGEKW
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CAG
CJTIS
COF
CS3
DM4
DU5
EBS
EFBJH
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HLW
HMG
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
LG5
LUGTX
LX2
LZ5
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SBG
SCC
SDF
SDG
SDP
SES
SEW
SIN
SPCBC
SSH
SSI
SSU
SSZ
T5K
TEORI
UNMZH
WUQ
XPP
ZMT
~G-
AATTM
AAYWO
AAYXX
ACIEU
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKYEP
ANKPU
APXCP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c356t-d39f90452490a3d16f9eb1f5fdea313db079c8cea3f50bf9373de329be52f9ab3
IEDL.DBID .~1
ISSN 1043-4666
1096-0023
IngestDate Fri Jul 11 00:17:15 EDT 2025
Wed Feb 19 02:03:00 EST 2025
Tue Jul 01 03:32:33 EDT 2025
Thu Apr 24 22:58:52 EDT 2025
Sat Nov 23 15:54:46 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Epithelial-mesenchymal transition
Ang-1
Choroidal melanoma
Akt/mTOR
Artesunate
Language English
License Copyright © 2024 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c356t-d39f90452490a3d16f9eb1f5fdea313db079c8cea3f50bf9373de329be52f9ab3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 39340959
PQID 3110912507
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3110912507
pubmed_primary_39340959
crossref_citationtrail_10_1016_j_cyto_2024_156771
crossref_primary_10_1016_j_cyto_2024_156771
elsevier_sciencedirect_doi_10_1016_j_cyto_2024_156771
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2024
2024-12-00
2024-Dec
20241201
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: December 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Cytokine (Philadelphia, Pa.)
PublicationTitleAlternate Cytokine
PublicationYear 2024
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Farhan, Silva, Xingan, Zhou, Zheng (b0130) 2021; 2021
Li, Guan, Liu, Liu, Song, Zhang, Zhao, Zhou, Gao (b0180) 2023; 14
Thurston (b0050) 2002; 200
Huang, Gan, Zhuang, Chen, Lu, Wang, Qi, Feng, Huang, Du, Zhang, Liu (b0110) 2022; 11
Li, Ma, Deng, Wu, Wang, Zhou (b0125) 2021; 766
Shim, Teh, Bapna, Kim, Koh, Mack, Ge (b0070) 2002; 279
Wang, Wang, Lu, Zhang, Liu, Zhou, Dai, Zheng (b0225) 2020; 11
Xu, Liu, Zhuang (b0190) 2022; 100
Yang, Zheng, Zhan, Fan (b0210) 2019; 11
Tanaka, Mori, Sakamoto, Makuuchi, Sugimachi, Wands (b0170) 1999; 103
Wei, Liu, Chen, Yin, Liu, Ouyang, Zeng, Nie, Chen (b0195) 2020; 24
Asnaghi, Gezgin, Tripathy, Handa, Merbs, van der Velden, Jager, Harbour, Eberhart (b0240) 2015; 21
Duran, Borriello, Karagiannis, Entenberg, Oktay, Condeelis (b0040) 2021; 13
Yao, Zhao, Yin, Wang, Gao (b0095) 2020; 41
Ye, Li, Li, Chang, Zhang (b0155) 2018; 15
Fallico, Raciti, Longo, Reibaldi, Bonfiglio, Russo, Caltabiano, Gattuso, Falzone, Avitabile (b0015) 2021; 58
Tang, Liu, Russell, Clements, Ling (b0030) 2019; 20
Smit, Jager, de Klein, Kiliҫ (b0020) 2020; 75
Lemmon, Schlessinger (b0150) 2010; 141
Damato (b0010) 2018; 66
Hawighorst, Skobe, Streit, Hong, Velasco, Brown, Riccardi, Lange-Asschenfeldt, Detmar (b0085) 2002; 160
Chen, Wong, Lim, Lim, Lin, Wang, Hua (b0200) 2017; 22
Chen, Liu, Mao, Tan, Mo, Meng, Cao, Zhong, Liu, Shan, Jiang (b0215) 2019; 18
Machein, Knedla, Knoth, Wagner, Neuschl, Plate (b0065) 2004; 165
Chen, Lu, Montoya-Durango, Liu, Dean, Darling, Kaplan, Dean, Gao, Liu (b0220) 2017; 7
Naumnik, Naumnik, Niewiarowska, Ossolinska, Chyczewska (b0060) 2013; 788
Yavuzyigitoglu, Koopmans, Verdijk, Vaarwater, Eussen, van Bodegom, Paridaens, Kiliç, de Klein (b0025) 2016; 123
Xue, Sheng, Duan, Yang, Ma, Xu, Wei, Shang, Li, Wan, Qin (b0035) 2021; 148
Liu, Bai, Yuan, Gong, Huang (b0045) 2008; 14
El Ket, Kendjo, Thellier, Assoumou, Potard, Taieb, Tantaoui, Caumes, Piarroux, Roussel, Buffet, Costagliola, Jauréguiberry (b0090) 2020; 70
Nunes, Pandey, Yadav, Goel, Ateeq (b0135) 2017; 19
Jing, Dong, Min, Runpeng, Xuewei, Ru, Yingru, Shengfa, Baoxian, Jinbo, Weidong, Rongbo (b0230) 2019; 120
Khanal (b0120) 2021; 152
Zheng, Pan (b0140) 2018; 18
Stoeltzing, Ahmad, Liu, McCarty, Wey, Parikh, Fan, Reinmuth, Kawaguchi, Bucana, Ellis (b0080) 2003; 63
Chen, Zeng, Kleibeuker, Buffa, Barberis, Leek, Roxanis, Zhang, Worth, Beech, Harris, Cai (b0055) 2016; 7
Greenshields, Fernando, Hoskin (b0105) 2019; 107
Soltysova, Sedlackova, Dvorska, Jasek, Chokhachi Baradaran, Horvathova Kajabova, Demkova, Buocikova, Kurucova, Lyskova, Furdova, Minarik, Babal, Dankova, Smolkova (b0235) 2020; 21
Krantz, Dave, Komatsubara, Marr, Carvajal (b0005) 2017; 11
Tian, Smit, Jücker (b0175) 2023; 24
Yu, Stamenkovic (b0165) 2001; 158
Hayes, Huang, Yu, Maisonpierre, Liu, Kern, Lippman, McLeskey, Li (b0075) 2000; 83
Hu, Ni, Teng (b0100) 2022; 13
Alzahrani (b0145) 2019; 59
Aoki, Fujishita (b0185) 2017; 407
Chen, Shi, Yang, Li, Guo, Pan (b0160) 2010; 92
Geng, Zhu, Yuan, Bai, Dou, Sui, Luo (b0115) 2021; 11
Kumar, Kalvala, Chu, Rosen, Forman, Marcucci, Chen, Pullarkat (b0205) 2017; 59
Machein (10.1016/j.cyto.2024.156771_b0065) 2004; 165
Shim (10.1016/j.cyto.2024.156771_b0070) 2002; 279
Lemmon (10.1016/j.cyto.2024.156771_b0150) 2010; 141
Li (10.1016/j.cyto.2024.156771_b0180) 2023; 14
Alzahrani (10.1016/j.cyto.2024.156771_b0145) 2019; 59
Smit (10.1016/j.cyto.2024.156771_b0020) 2020; 75
Greenshields (10.1016/j.cyto.2024.156771_b0105) 2019; 107
Li (10.1016/j.cyto.2024.156771_b0125) 2021; 766
Chen (10.1016/j.cyto.2024.156771_b0220) 2017; 7
Fallico (10.1016/j.cyto.2024.156771_b0015) 2021; 58
Tang (10.1016/j.cyto.2024.156771_b0030) 2019; 20
Naumnik (10.1016/j.cyto.2024.156771_b0060) 2013; 788
Nunes (10.1016/j.cyto.2024.156771_b0135) 2017; 19
Liu (10.1016/j.cyto.2024.156771_b0045) 2008; 14
Hawighorst (10.1016/j.cyto.2024.156771_b0085) 2002; 160
Krantz (10.1016/j.cyto.2024.156771_b0005) 2017; 11
Chen (10.1016/j.cyto.2024.156771_b0200) 2017; 22
Wei (10.1016/j.cyto.2024.156771_b0195) 2020; 24
Kumar (10.1016/j.cyto.2024.156771_b0205) 2017; 59
Aoki (10.1016/j.cyto.2024.156771_b0185) 2017; 407
Geng (10.1016/j.cyto.2024.156771_b0115) 2021; 11
Yao (10.1016/j.cyto.2024.156771_b0095) 2020; 41
Asnaghi (10.1016/j.cyto.2024.156771_b0240) 2015; 21
Ye (10.1016/j.cyto.2024.156771_b0155) 2018; 15
Tian (10.1016/j.cyto.2024.156771_b0175) 2023; 24
Duran (10.1016/j.cyto.2024.156771_b0040) 2021; 13
Khanal (10.1016/j.cyto.2024.156771_b0120) 2021; 152
Zheng (10.1016/j.cyto.2024.156771_b0140) 2018; 18
Yavuzyigitoglu (10.1016/j.cyto.2024.156771_b0025) 2016; 123
El Ket (10.1016/j.cyto.2024.156771_b0090) 2020; 70
Wang (10.1016/j.cyto.2024.156771_b0225) 2020; 11
Chen (10.1016/j.cyto.2024.156771_b0055) 2016; 7
Stoeltzing (10.1016/j.cyto.2024.156771_b0080) 2003; 63
Yang (10.1016/j.cyto.2024.156771_b0210) 2019; 11
Damato (10.1016/j.cyto.2024.156771_b0010) 2018; 66
Soltysova (10.1016/j.cyto.2024.156771_b0235) 2020; 21
Chen (10.1016/j.cyto.2024.156771_b0160) 2010; 92
Xu (10.1016/j.cyto.2024.156771_b0190) 2022; 100
Tanaka (10.1016/j.cyto.2024.156771_b0170) 1999; 103
Hayes (10.1016/j.cyto.2024.156771_b0075) 2000; 83
Farhan (10.1016/j.cyto.2024.156771_b0130) 2021; 2021
Yu (10.1016/j.cyto.2024.156771_b0165) 2001; 158
Huang (10.1016/j.cyto.2024.156771_b0110) 2022; 11
Chen (10.1016/j.cyto.2024.156771_b0215) 2019; 18
Jing (10.1016/j.cyto.2024.156771_b0230) 2019; 120
Xue (10.1016/j.cyto.2024.156771_b0035) 2021; 148
Thurston (10.1016/j.cyto.2024.156771_b0050) 2002; 200
Hu (10.1016/j.cyto.2024.156771_b0100) 2022; 13
References_xml – volume: 83
  start-page: 1154
  year: 2000
  end-page: 1160
  ident: b0075
  article-title: Expression and function of angiopoietin-1 in breast cancer
  publication-title: Br. J. Cancer
– volume: 11
  start-page: 279
  year: 2017
  end-page: 289
  ident: b0005
  article-title: Uveal melanoma: epidemiology, etiology, and treatment of primary disease
  publication-title: Clinical Ophthalmology (auckland, NZ)
– volume: 160
  start-page: 1381
  year: 2002
  end-page: 1392
  ident: b0085
  article-title: Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth
  publication-title: Am. J. Pathol.
– volume: 75
  year: 2020
  ident: b0020
  article-title: Uveal melanoma: Towards a molecular understanding
  publication-title: Prog Retin Eye Res
– volume: 14
  start-page: 1575
  year: 2008
  end-page: 1581
  ident: b0045
  article-title: Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer
  publication-title: World J. Gastroenterol.
– volume: 141
  start-page: 1117
  year: 2010
  end-page: 1134
  ident: b0150
  article-title: Cell signaling by receptor tyrosine kinases
  publication-title: Cell
– volume: 11
  start-page: 5301
  year: 2019
  end-page: 5312
  ident: b0210
  article-title: An emerging tumor invasion mechanism about the collective cell migration
  publication-title: Am. J. Transl. Res.
– volume: 59
  start-page: 125
  year: 2019
  end-page: 132
  ident: b0145
  article-title: PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
  publication-title: Semin. Cancer Biol.
– volume: 158
  start-page: 563
  year: 2001
  end-page: 570
  ident: b0165
  article-title: Angiopoietin-2 is implicated in the regulation of tumor angiogenesis
  publication-title: Am. J. Pathol.
– volume: 120
  start-page: 6026
  year: 2019
  end-page: 6034
  ident: b0230
  article-title: Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma
  publication-title: J Cell Biochem
– volume: 63
  start-page: 3370
  year: 2003
  end-page: 3377
  ident: b0080
  article-title: Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors
  publication-title: Cancer Res.
– volume: 20
  year: 2019
  ident: b0030
  article-title: Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway
  publication-title: Int J Mol Sci
– volume: 11
  year: 2021
  ident: b0115
  article-title: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis
  publication-title: Front Oncol
– volume: 41
  start-page: 1609
  year: 2020
  end-page: 1620
  ident: b0095
  article-title: Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells
  publication-title: Acta Pharmacol. Sin.
– volume: 13
  start-page: 6590
  year: 2022
  end-page: 6599
  ident: b0100
  article-title: Effects of artesunate on the malignant biological behaviors of non-small cell lung cancer in human and its mechanism
  publication-title: Bioengineered
– volume: 70
  start-page: 280
  year: 2020
  end-page: 287
  ident: b0090
  article-title: Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France
  publication-title: Clin. Infect. Dis.
– volume: 19
  start-page: 333
  year: 2017
  end-page: 345
  ident: b0135
  article-title: Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens
  publication-title: Neoplasia (new York, NY)
– volume: 152
  start-page: 387
  year: 2021
  end-page: 400
  ident: b0120
  article-title: Antimalarial and anticancer properties of artesunate and other artemisinins: current development
  publication-title: Monatsh. Chem.
– volume: 200
  start-page: 575
  year: 2002
  end-page: 580
  ident: b0050
  article-title: Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage
  publication-title: J. Anat.
– volume: 103
  start-page: 341
  year: 1999
  end-page: 345
  ident: b0170
  article-title: Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
  publication-title: J Clin Invest
– volume: 407
  start-page: 153
  year: 2017
  end-page: 189
  ident: b0185
  article-title: Oncogenic Roles of the PI3K/AKT/mTOR Axis
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 165
  start-page: 1557
  year: 2004
  end-page: 1570
  ident: b0065
  article-title: Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model
  publication-title: Am. J. Pathol.
– volume: 766
  year: 2021
  ident: b0125
  article-title: Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway
  publication-title: Gene
– volume: 123
  start-page: 1118
  year: 2016
  end-page: 1128
  ident: b0025
  article-title: Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases
  publication-title: Ophthalmology
– volume: 7
  start-page: 45
  year: 2017
  ident: b0220
  article-title: ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression
  publication-title: Sci Rep
– volume: 13
  year: 2021
  ident: b0040
  article-title: Targeting Tie2 in the Tumor Microenvironment: From Angiogenesis to Dissemination
  publication-title: Cancers (basel)
– volume: 107
  start-page: 10
  year: 2019
  end-page: 22
  ident: b0105
  article-title: The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells
  publication-title: Exp Mol Pathol
– volume: 21
  year: 2020
  ident: b0235
  article-title: Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy
  publication-title: Int J Mol Sci
– volume: 7
  start-page: 9353
  year: 2016
  end-page: 9367
  ident: b0055
  article-title: Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth
  publication-title: Oncotarget
– volume: 14
  start-page: 188
  year: 2023
  ident: b0180
  article-title: PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
  publication-title: Cell Death Dis.
– volume: 22
  year: 2017
  ident: b0200
  article-title: Artesunate Activates the Intrinsic Apoptosis of HCT116 Cells through the Suppression of Fatty Acid Synthesis and the NF-κB Pathway
  publication-title: Molecules
– volume: 2021
  start-page: 9911537
  year: 2021
  ident: b0130
  article-title: Artemisinin Inhibits the Migration and Invasion in Uveal Melanoma via Inhibition of the PI3K/AKT/mTOR Signaling Pathway
  publication-title: Oxid. Med. Cell. Longev.
– volume: 148
  start-page: 1519
  year: 2021
  end-page: 1528
  ident: b0035
  article-title: Tie2-expressing monocytes as a novel angiogenesis-related cellular biomarker for non-small cell lung cancer
  publication-title: Int. J. Cancer
– volume: 788
  start-page: 341
  year: 2013
  end-page: 348
  ident: b0060
  article-title: Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study
  publication-title: Adv. Exp. Med. Biol.
– volume: 58
  year: 2021
  ident: b0015
  article-title: Current molecular and clinical insights into uveal melanoma (Review)
  publication-title: Int. J. Oncol.
– volume: 92
  start-page: 587
  year: 2010
  end-page: 597
  ident: b0160
  article-title: Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
  publication-title: Int. J. Hematol.
– volume: 11
  start-page: 1197
  year: 2020
  end-page: 1207
  ident: b0225
  article-title: Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7
  publication-title: Bioengineered
– volume: 279
  start-page: 299
  year: 2002
  end-page: 309
  ident: b0070
  article-title: Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice
  publication-title: Exp. Cell Res.
– volume: 24
  year: 2023
  ident: b0175
  article-title: The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
  publication-title: Int J Mol Sci
– volume: 66
  start-page: 187
  year: 2018
  end-page: 199
  ident: b0010
  article-title: Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - A personal view
  publication-title: Prog Retin Eye Res
– volume: 59
  start-page: 124
  year: 2017
  end-page: 135
  ident: b0205
  article-title: Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia
  publication-title: Leuk. Res.
– volume: 21
  start-page: 919
  year: 2015
  end-page: 929
  ident: b0240
  article-title: EMT-associated factors promote invasive properties of uveal melanoma cells
  publication-title: Mol. Vis.
– volume: 11
  year: 2022
  ident: b0110
  article-title: Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy
  publication-title: Cells-Basel
– volume: 100
  start-page: 85
  year: 2022
  end-page: 92
  ident: b0190
  article-title: Artesunate inhibits proliferation, migration, and invasion of thyroid cancer cells by regulating the PI3K/AKT/FKHR pathway
  publication-title: Biochem Cell Biol
– volume: 15
  start-page: 1313
  year: 2018
  end-page: 1318
  ident: b0155
  article-title: Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway
  publication-title: Oncol. Lett.
– volume: 18
  start-page: 101
  year: 2019
  ident: b0215
  article-title: Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy
  publication-title: Mol Cancer
– volume: 18
  start-page: 988
  year: 2018
  end-page: 998
  ident: b0140
  article-title: The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth
  publication-title: Migration and Invasion of Uveal Melanoma Cells, Curr Cancer Drug Targets
– volume: 24
  start-page: 276
  year: 2020
  end-page: 284
  ident: b0195
  article-title: Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence
  publication-title: J. Cell Mol. Med.
– volume: 158
  start-page: 563
  year: 2001
  ident: 10.1016/j.cyto.2024.156771_b0165
  article-title: Angiopoietin-2 is implicated in the regulation of tumor angiogenesis
  publication-title: Am. J. Pathol..
  doi: 10.1016/S0002-9440(10)63998-3
– volume: 407
  start-page: 153
  year: 2017
  ident: 10.1016/j.cyto.2024.156771_b0185
  article-title: Oncogenic Roles of the PI3K/AKT/mTOR Axis
  publication-title: Curr. Top. Microbiol. Immunol..
– volume: 58
  year: 2021
  ident: 10.1016/j.cyto.2024.156771_b0015
  article-title: Current molecular and clinical insights into uveal melanoma (Review)
  publication-title: Int. J. Oncol..
  doi: 10.3892/ijo.2021.5190
– volume: 66
  start-page: 187
  year: 2018
  ident: 10.1016/j.cyto.2024.156771_b0010
  article-title: Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - A personal view
  publication-title: Prog Retin Eye Res.
  doi: 10.1016/j.preteyeres.2018.03.004
– volume: 11
  start-page: 1197
  year: 2020
  ident: 10.1016/j.cyto.2024.156771_b0225
  article-title: Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7
  publication-title: Bioengineered.
  doi: 10.1080/21655979.2020.1834727
– volume: 766
  year: 2021
  ident: 10.1016/j.cyto.2024.156771_b0125
  article-title: Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway
  publication-title: Gene.
  doi: 10.1016/j.gene.2020.145134
– volume: 20
  year: 2019
  ident: 10.1016/j.cyto.2024.156771_b0030
  article-title: Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms20051164
– volume: 7
  start-page: 9353
  year: 2016
  ident: 10.1016/j.cyto.2024.156771_b0055
  article-title: Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.6981
– volume: 15
  start-page: 1313
  year: 2018
  ident: 10.1016/j.cyto.2024.156771_b0155
  article-title: Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway
  publication-title: Oncol. Lett..
– volume: 21
  start-page: 919
  year: 2015
  ident: 10.1016/j.cyto.2024.156771_b0240
  article-title: EMT-associated factors promote invasive properties of uveal melanoma cells
  publication-title: Mol. Vis..
– volume: 22
  year: 2017
  ident: 10.1016/j.cyto.2024.156771_b0200
  article-title: Artesunate Activates the Intrinsic Apoptosis of HCT116 Cells through the Suppression of Fatty Acid Synthesis and the NF-κB Pathway
  publication-title: Molecules.
  doi: 10.3390/molecules22081272
– volume: 123
  start-page: 1118
  year: 2016
  ident: 10.1016/j.cyto.2024.156771_b0025
  article-title: Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases
  publication-title: Ophthalmology.
  doi: 10.1016/j.ophtha.2016.01.023
– volume: 148
  start-page: 1519
  year: 2021
  ident: 10.1016/j.cyto.2024.156771_b0035
  article-title: Tie2-expressing monocytes as a novel angiogenesis-related cellular biomarker for non-small cell lung cancer
  publication-title: Int. J. Cancer.
  doi: 10.1002/ijc.33381
– volume: 75
  year: 2020
  ident: 10.1016/j.cyto.2024.156771_b0020
  article-title: Uveal melanoma: Towards a molecular understanding
  publication-title: Prog Retin Eye Res.
  doi: 10.1016/j.preteyeres.2019.100800
– volume: 70
  start-page: 280
  year: 2020
  ident: 10.1016/j.cyto.2024.156771_b0090
  article-title: Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France
  publication-title: Clin. Infect. Dis..
  doi: 10.1093/cid/ciz206
– volume: 83
  start-page: 1154
  year: 2000
  ident: 10.1016/j.cyto.2024.156771_b0075
  article-title: Expression and function of angiopoietin-1 in breast cancer
  publication-title: Br. J. Cancer.
  doi: 10.1054/bjoc.2000.1437
– volume: 13
  year: 2021
  ident: 10.1016/j.cyto.2024.156771_b0040
  article-title: Targeting Tie2 in the Tumor Microenvironment: From Angiogenesis to Dissemination
  publication-title: Cancers (basel).
  doi: 10.3390/cancers13225730
– volume: 100
  start-page: 85
  year: 2022
  ident: 10.1016/j.cyto.2024.156771_b0190
  article-title: Artesunate inhibits proliferation, migration, and invasion of thyroid cancer cells by regulating the PI3K/AKT/FKHR pathway
  publication-title: Biochem Cell Biol.
  doi: 10.1139/bcb-2021-0275
– volume: 63
  start-page: 3370
  year: 2003
  ident: 10.1016/j.cyto.2024.156771_b0080
  article-title: Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors
  publication-title: Cancer Res..
– volume: 11
  year: 2022
  ident: 10.1016/j.cyto.2024.156771_b0110
  article-title: Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy
  publication-title: Cells-Basel.
– volume: 152
  start-page: 387
  year: 2021
  ident: 10.1016/j.cyto.2024.156771_b0120
  article-title: Antimalarial and anticancer properties of artesunate and other artemisinins: current development
  publication-title: Monatsh. Chem..
  doi: 10.1007/s00706-021-02759-x
– volume: 41
  start-page: 1609
  year: 2020
  ident: 10.1016/j.cyto.2024.156771_b0095
  article-title: Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells
  publication-title: Acta Pharmacol. Sin..
  doi: 10.1038/s41401-020-0395-5
– volume: 24
  start-page: 276
  year: 2020
  ident: 10.1016/j.cyto.2024.156771_b0195
  article-title: Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence
  publication-title: J. Cell Mol. Med..
  doi: 10.1111/jcmm.14717
– volume: 11
  year: 2021
  ident: 10.1016/j.cyto.2024.156771_b0115
  article-title: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2021.714646
– volume: 59
  start-page: 124
  year: 2017
  ident: 10.1016/j.cyto.2024.156771_b0205
  article-title: Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia
  publication-title: Leuk. Res..
  doi: 10.1016/j.leukres.2017.05.007
– volume: 200
  start-page: 575
  year: 2002
  ident: 10.1016/j.cyto.2024.156771_b0050
  article-title: Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage
  publication-title: J. Anat..
  doi: 10.1046/j.1469-7580.2002.00061.x
– volume: 18
  start-page: 988
  year: 2018
  ident: 10.1016/j.cyto.2024.156771_b0140
  article-title: The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth
  publication-title: Migration and Invasion of Uveal Melanoma Cells, Curr Cancer Drug Targets.
  doi: 10.2174/1568009618666180425142653
– volume: 11
  start-page: 279
  year: 2017
  ident: 10.1016/j.cyto.2024.156771_b0005
  article-title: Uveal melanoma: epidemiology, etiology, and treatment of primary disease
  publication-title: Clinical Ophthalmology (auckland, NZ).
  doi: 10.2147/OPTH.S89591
– volume: 24
  year: 2023
  ident: 10.1016/j.cyto.2024.156771_b0175
  article-title: The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
  publication-title: Int J Mol Sci.
– volume: 2021
  start-page: 9911537
  year: 2021
  ident: 10.1016/j.cyto.2024.156771_b0130
  article-title: Artemisinin Inhibits the Migration and Invasion in Uveal Melanoma via Inhibition of the PI3K/AKT/mTOR Signaling Pathway
  publication-title: Oxid. Med. Cell. Longev..
  doi: 10.1155/2021/9911537
– volume: 103
  start-page: 341
  year: 1999
  ident: 10.1016/j.cyto.2024.156771_b0170
  article-title: Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
  publication-title: J Clin Invest.
  doi: 10.1172/JCI4891
– volume: 165
  start-page: 1557
  year: 2004
  ident: 10.1016/j.cyto.2024.156771_b0065
  article-title: Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model
  publication-title: Am. J. Pathol..
  doi: 10.1016/S0002-9440(10)63413-X
– volume: 279
  start-page: 299
  year: 2002
  ident: 10.1016/j.cyto.2024.156771_b0070
  article-title: Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice
  publication-title: Exp. Cell Res..
  doi: 10.1006/excr.2002.5597
– volume: 92
  start-page: 587
  year: 2010
  ident: 10.1016/j.cyto.2024.156771_b0160
  article-title: Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
  publication-title: Int. J. Hematol..
  doi: 10.1007/s12185-010-0697-3
– volume: 14
  start-page: 188
  year: 2023
  ident: 10.1016/j.cyto.2024.156771_b0180
  article-title: PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
  publication-title: Cell Death Dis..
  doi: 10.1038/s41419-023-05712-4
– volume: 160
  start-page: 1381
  year: 2002
  ident: 10.1016/j.cyto.2024.156771_b0085
  article-title: Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth
  publication-title: Am. J. Pathol..
  doi: 10.1016/S0002-9440(10)62565-5
– volume: 107
  start-page: 10
  year: 2019
  ident: 10.1016/j.cyto.2024.156771_b0105
  article-title: The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells
  publication-title: Exp Mol Pathol.
  doi: 10.1016/j.yexmp.2019.01.006
– volume: 18
  start-page: 101
  year: 2019
  ident: 10.1016/j.cyto.2024.156771_b0215
  article-title: Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy
  publication-title: Mol Cancer.
  doi: 10.1186/s12943-019-1030-2
– volume: 7
  start-page: 45
  year: 2017
  ident: 10.1016/j.cyto.2024.156771_b0220
  article-title: ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression
  publication-title: Sci Rep.
  doi: 10.1038/s41598-017-00079-x
– volume: 13
  start-page: 6590
  year: 2022
  ident: 10.1016/j.cyto.2024.156771_b0100
  article-title: Effects of artesunate on the malignant biological behaviors of non-small cell lung cancer in human and its mechanism
  publication-title: Bioengineered.
  doi: 10.1080/21655979.2022.2042141
– volume: 14
  start-page: 1575
  year: 2008
  ident: 10.1016/j.cyto.2024.156771_b0045
  article-title: Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer
  publication-title: World J. Gastroenterol..
  doi: 10.3748/wjg.14.1575
– volume: 21
  year: 2020
  ident: 10.1016/j.cyto.2024.156771_b0235
  article-title: Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms21249651
– volume: 59
  start-page: 125
  year: 2019
  ident: 10.1016/j.cyto.2024.156771_b0145
  article-title: PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
  publication-title: Semin. Cancer Biol..
  doi: 10.1016/j.semcancer.2019.07.009
– volume: 11
  start-page: 5301
  year: 2019
  ident: 10.1016/j.cyto.2024.156771_b0210
  article-title: An emerging tumor invasion mechanism about the collective cell migration
  publication-title: Am. J. Transl. Res..
– volume: 120
  start-page: 6026
  year: 2019
  ident: 10.1016/j.cyto.2024.156771_b0230
  article-title: Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma
  publication-title: J Cell Biochem.
  doi: 10.1002/jcb.27889
– volume: 788
  start-page: 341
  year: 2013
  ident: 10.1016/j.cyto.2024.156771_b0060
  article-title: Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study
  publication-title: Adv. Exp. Med. Biol..
  doi: 10.1007/978-94-007-6627-3_46
– volume: 19
  start-page: 333
  year: 2017
  ident: 10.1016/j.cyto.2024.156771_b0135
  article-title: Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens
  publication-title: Neoplasia (new York, NY).
  doi: 10.1016/j.neo.2017.02.002
– volume: 141
  start-page: 1117
  year: 2010
  ident: 10.1016/j.cyto.2024.156771_b0150
  article-title: Cell signaling by receptor tyrosine kinases
  publication-title: Cell.
  doi: 10.1016/j.cell.2010.06.011
SSID ssj0009377
Score 2.4401703
Snippet [Display omitted] The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of...
The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types....
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 156771
SubjectTerms Akt/mTOR
Ang-1
Angiopoietin-1 - metabolism
Animals
Antineoplastic Agents - pharmacology
Artesunate
Artesunate - pharmacology
Artesunate - therapeutic use
Carcinogenesis - drug effects
Carcinogenesis - genetics
Carcinogenesis - metabolism
Carcinogenesis - pathology
Cell Line, Tumor
Cell Movement - drug effects
Cell Proliferation - drug effects
Choroidal melanoma
Epithelial-mesenchymal transition
Epithelial-Mesenchymal Transition - drug effects
Female
Humans
Melanoma - drug therapy
Melanoma - genetics
Melanoma - metabolism
Melanoma - pathology
Mice
Mice, Inbred BALB C
Mice, Nude
Proto-Oncogene Proteins c-akt - metabolism
Signal Transduction - drug effects
TOR Serine-Threonine Kinases - metabolism
Xenograft Model Antitumor Assays
Title Ang-1 promotes tumorigenesis and mediates the anti-cancer effects of Artesunate on Choroidal melanoma via the regulation of Akt/mTOR signaling pathway
URI https://dx.doi.org/10.1016/j.cyto.2024.156771
https://www.ncbi.nlm.nih.gov/pubmed/39340959
https://www.proquest.com/docview/3110912507
Volume 184
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIhCXqi2vbWllJG4o3SR2kvVxtaJaWLVIpRW9WX7SQDdZ7WZBe-Fn8HuZiZMiDu2BU2THli3PZB7xNzOEvDXe53mhVCSsAwclS1ykXJJH3GubWND3ur0uODvPp1f843V2vUUmfSwMwio72R9keiutu55hd5rDRVkOP4MjwThY34iCTMHsxQh2XiCXn_z6C_MA9VuEjAQswtFd4EzAeJlNgwGAKT8BN6YokvuU033GZ6uETnfJTmc90nHY4B7ZctU-eRzqSW72yZOz7qb8Gfk9rr5GCV20aDu3os16jjWwULKVK6oqS9uYkfbVjYOOpowMcsCSdhAPWntcyK3WFQyjdUUnN_WyLi1sYO5uVVXPFf1Rqnb-MpS0ByK30743w_nlpwuK6BCFAe8UKx__VJvn5Or0_eVkGnU1GCLDsryJLBNeYNp1LmLFbJJ7AdLdZ946xRJmdVwIMzLQ8FmsPZw2s46lQrss9UJp9oJsV3XlXhFqrYmVSDOTa8e1FXoEnrDmdqRdwrThA5L0hy9Nl6Ac62Tcyh6J9k0iwSQSTAaCDci7uzmLkJ7jwdFZT1P5D5NJ0B8PznvTM4CErw-vVFTl6vVKMkzYCjZiXAzIy8AZd_tggnH8y3rwn6sekqfYCtiZ12S7Wa7dEVhAjT5uWfyYPBp_mE3P8Tm7-DL7A3LCCX0
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEY8LgvJaWsBI3FC6Sewk62O1olqgWyTYSr1ZfraBbrLazYL2ws_g93YmTlpxaA8cY3tkyzOeGcffzBDy3nif54VSkbAOLihZ4iLlkjziXtvEgr3X7XPB9DifnPDPp9npFhn3sTAIq-x0f9DprbbuWobdbg4XZTn8DhcJxsH7RhRkCm7vHXKXw_HFMgb7f65xHmB_i5CSgEU4vIucCSAvs2kwAjDl-3CPKYrkJut0k_fZWqHDx-RR5z7Sg7DCJ2TLVTvkXigoudkh96fdU_lT8vegOosSumjhdm5Fm_Uci2ChaitXVFWWtkEjbde5g4amjAyKwJJ2GA9ae5zIrdYVDKN1Rcfn9bIuLSxg7i5UVc8V_VWqln4ZatoDl1uyn81wPvv6jSI8RGHEO8XSx7_V5hk5Ofw4G0-irghDZFiWN5FlwgvMu85FrJhNci9AvfvMW6dYwqyOC2FGBj58FmsPu82sY6nQLku9UJo9J9tVXbmXhFprYiXSzOTacW2FHsFVWHM70i5h2vABSfrNl6bLUI6FMi5kD0X7IZFhEhkmA8MG5MMVzSLk57h1dNbzVP4jZRIMyK1073oBkHD88E1FVa5eryTDjK3gJMbFgLwIknG1DiYYx9-sr_5z1rfkwWQ2PZJHn46_7JKH2BOANHtku1mu3Wtwhxr9phX3SxwiCWg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ang-1+promotes+tumorigenesis+and+mediates+the+anti-cancer+effects+of+Artesunate+on+Choroidal+melanoma+via+the+regulation+of+Akt%2FmTOR+signaling+pathway&rft.jtitle=Cytokine+%28Philadelphia%2C+Pa.%29&rft.au=Yao%2C+Ningning&rft.au=Ma%2C+Qingyue&rft.au=Yi%2C+Wendan&rft.au=Liu%2C+Yichong&rft.date=2024-12-01&rft.issn=1096-0023&rft.eissn=1096-0023&rft.volume=184&rft.spage=156771&rft_id=info:doi/10.1016%2Fj.cyto.2024.156771&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-4666&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-4666&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-4666&client=summon